- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
- You can view the full Merck Ratings Report.
Jim Cramer is opting for stocks like Allergan and Johnson & Johnson over Valeant Pharmaceuticals.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on quarterly results from Valeant Pharmaceuticals on Tuesday.
Without further ado, here's a look at this week's Rocket Stocks.